Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

685
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
685
The Blood-brain Barrier00:49

The Blood-brain Barrier

46.5K
Overview
46.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of Residency Training for the Provision of Comprehensive Clinical Pharmacy Services.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Prevalence and prediction of augmented renal clearance in the neurocritical care population.

Journal of neurocritical care·2026
Same author

Pharmacist's Guide to Common Intracranial Bleeding Terms and Treatments.

The Annals of pharmacotherapy·2025
Same author

Multicenter comparison of antiplatelet treatment strategies for urgent/emergent neuroendovascular stenting.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2023
Same author

Personalized antiseizure medication therapy in critically ill adult patients.

Pharmacotherapy·2023
Same author

Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study.

Pharmacotherapy·2023
Same journal

Impact of Omaveloxolone on Serum Lipids in Patients with Friedreich Ataxia: A 1-Year Real-World Analysis.

CNS drugs·2026
Same journal

Emerging Pharmacological Strategies for Trigeminal Neuralgia.

CNS drugs·2026
Same journal

Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysis.

CNS drugs·2026
Same journal

Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD.

CNS drugs·2026
Same journal

Isoform-Specific NaV Modulation in Painful Chemotherapy-Induced Neuropathy: Promise, Limitations, and a Clinical Agenda.

CNS drugs·2026
Same journal

Correction: Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy.

CNS drugs·2026
See all related articles

Related Experiment Video

Updated: May 22, 2025

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
06:50

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

Published on: June 10, 2020

1.8K

Update on Neuroprotection after Traumatic Brain Injury.

Aaron M Cook1, Morgan Michas2, Blake Robbins2

  • 1Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, USA. amcook0@uky.edu.

CNS Drugs
|March 15, 2025
PubMed
Summary
This summary is machine-generated.

Traumatic brain injury (TBI) remains a significant global health challenge. This review explores current neuroprotective strategies, biomarkers, and TBI classifications, highlighting future research directions for acute TBI management.

More Related Videos

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells
09:29

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells

Published on: July 10, 2019

10.7K
Author Spotlight: Optimizing Rodent Models for Investigating the Mechanisms and Rehabilitation in Repeated Mild Traumatic Brain Injury
04:47

Author Spotlight: Optimizing Rodent Models for Investigating the Mechanisms and Rehabilitation in Repeated Mild Traumatic Brain Injury

Published on: April 19, 2024

354

Related Experiment Videos

Last Updated: May 22, 2025

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
06:50

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

Published on: June 10, 2020

1.8K
Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells
09:29

Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells

Published on: July 10, 2019

10.7K
Author Spotlight: Optimizing Rodent Models for Investigating the Mechanisms and Rehabilitation in Repeated Mild Traumatic Brain Injury
04:47

Author Spotlight: Optimizing Rodent Models for Investigating the Mechanisms and Rehabilitation in Repeated Mild Traumatic Brain Injury

Published on: April 19, 2024

354

Area of Science:

  • Neuroscience
  • Trauma Surgery
  • Pharmacology

Background:

  • Traumatic brain injury (TBI) is a leading cause of death and disability globally.
  • Despite extensive research into neuroprotective agents for moderate-to-severe TBI, effective therapeutic options remain elusive.
  • Understanding the secondary injury cascade is crucial for developing new treatments.

Purpose of the Study:

  • To review the current understanding of TBI pathophysiology.
  • To discuss recent clinical trials of novel neuroprotective agents.
  • To explore emerging biomarkers and future directions in acute TBI research.

Main Methods:

  • Literature review of recent clinical trials and research studies on TBI.
  • Analysis of emerging pharmacotherapy options for neuroprotection.
  • Examination of advancements in TBI diagnosis and prognosis using biomarkers.

Main Results:

  • Several neuroprotective agents, including tranexamic acid, progesterone, and citicholine, are under investigation.
  • Biomarkers for TBI diagnosis and prognosis are increasingly utilized in clinical settings.
  • Attention is growing towards understanding mild TBI, blast injuries, and subdural hematomas.

Conclusions:

  • Despite challenges, research continues to explore new pharmacotherapies and strategies for TBI.
  • Biomarker development offers improved diagnostic and prognostic capabilities for TBI.
  • A comprehensive approach considering TBI spectrum and pathophysiology is essential for future therapeutic advancements.